TY  - JOUR
AU  - Chen-Liang, Tzu-Hua
AU  - Martín-Santos, Taida
AU  - Jerez, Andrés
AU  - Rodríguez-García, Guillermo
AU  - Senent, Leonor
AU  - Martínez-Millán, Cristina
AU  - Muiña, Begoña
AU  - Orero, Mayte
AU  - Teruel, Anabel
AU  - Martín, Alejandro
AU  - Gómez-Espuch, Joaquín
AU  - Kennedy, Kyra
AU  - Benet, Carmen
AU  - Raya, José María
AU  - Fernández-González, Marta
AU  - de la Cruz, Fátima
AU  - Guinot, Marta
AU  - Villegas, Carolina
AU  - Ballester, Isabel
AU  - Baile, Mónica
AU  - Moya, María
AU  - López-Jiménez, Javier
AU  - Frutos, Laura
AU  - Navarro, José Luis
AU  - Uña, Jon
AU  - Fernández-López, Rosa
AU  - Igua, Carolina
AU  - Contreras, José
AU  - Sánchez-Vañó, Raquel
AU  - Cozar, María Del Puig
AU  - Tamayo, Pilar
AU  - Mucientes, Jorge
AU  - Sánchez-Blanco, José Javier
AU  - Pérez-Ceballos, Elena
AU  - Ortuño, Francisco José
PY  - 2017
DO  - 10.1002/cam4.1205
UR  - http://hdl.handle.net/10668/11625
T2  - Cancer medicine
AB  - Several studies have reported uneven results when evaluating the prognostic value of bone marrow biopsy (BMB) and PET/CT as part of the staging of diffuse large B-cell lymphoma (DLBCL). The heterogeneity of the inclusion criteria and not taking into...
LA  - en
KW  - Bone marrow biopsy
KW  - PET/CT
KW  - diffuse large B-cell lymphoma
KW  - outcomes research
KW  - Adolescent
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biopsy
KW  - Bone Marrow
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Follow-Up Studies
KW  - Health Status
KW  - Humans
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Positron Emission Tomography Computed Tomography
KW  - Predictive Value of Tests
KW  - Prednisone
KW  - Retrospective Studies
KW  - Rituximab
KW  - Survival Rate
KW  - Vincristine
KW  - Young Adult
KW  - beta 2-Microglobulin
TI  - Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma.
TY  - research article
VL  - 6
ER  -